期刊文献+

血管内皮生长因子检测试剂盒质控标准的确定

Determination of quality control standard for detection kit for vascular endothelial growth factor
原文传递
导出
摘要 目的确定血管内皮生长因子(Vascular endothelial growth factor,VEGF)检测试剂盒的质控标准。方法对已制备的VEGF检测试剂盒反应体系的线性范围、最低检出限、精密性、准确性、稳定性进行质量评价,确定质控标准。结果 VEGF检测试剂盒的线性范围为0~400 pg/ml;最低检出限为0 pg/ml;检测不同浓度VEGF样品的批内精密性为9.83%~13.73%,不同时间检测VEGF的批内精密性为5.47%~14.08%,批间精密性为7.88%;检测不同浓度VEGF的回收率为94%~105%,确定试剂盒的质控标准为批内、批间精密性<15%,回收率在90%~110%之间。3批试剂盒于4℃分别放置6个月,各项指标均符合已确定的质控标准。结论已确定了VEGF检测试剂盒的质控标准,为其进一步应用于临床奠定了基础。 Objective To determine the quality control standard for detection kit for vascular endothelial growth factor (VEGF). Methods The prepared detection kit for VEGF was evaluated for linear range, minimum detection limit, precision, accuracy and stability, based on which the quality control standard was determined. Results The linear range and minimum detection limit of the prepared kit were 0 N 400 and 0 pg / ml respectively. The intra-precision of detection results of VEGF samples at different concentrations and time points were 9. 83% N 13.73% and 5.47% - 14. 08% respectively. However, the inter-precision of detection results was 7. 88%. The recovery rate of VEGF at various concentrations was 94% -105%. The quality control standard for the kit was determined as follows: both the intra- and inter-precisions were less than 15%, and the recovery rate was 90% -110%. After storage at 4℃ for 6 months, all the indexes of the kit met the determined standard. Conclusion The quality control standard for detection kit for VEGF was determined, which laid a foundation of further application of the kit in clinic.
出处 《中国生物制品学杂志》 CAS CSCD 2012年第2期203-205,共3页 Chinese Journal of Biologicals
基金 北京市科研攻关项目(Z07000200540703) 北京市海淀区科研攻关项目(K2008102)
关键词 血管内皮生长因子 精密性 准确性 Vascular endothelial growth factor (VEGF) Precision Accuracy
  • 相关文献

参考文献10

  • 1Poon RT,Lau C,Pang R,et al.High serum vascular endothelialgrowth factor levels predict poor prognosis after radiofrequency ab-lation of hepatocellular carcinoma:importance of tumor biomarkerin ablative therapies[J].Ann Surg Oncol,2007,14(6):1835-1845.
  • 2Ferrero S,Nicoletti A,Ragni N.Measurement of serum vascularendothelial growth factor in breast cancer patients[J].Intern MedJ,2005,35(5):310-311.
  • 3Brattstrom D,Bergqwist M,Hesselius P,et al.Serum VEGF andbFGF adds prognostic information in patients with normal plateletcounts when sampled before,during and after treatment for locallyadvanced non-small cell lung cancer[J].Lung Cancer,2004,43(1):55-62.
  • 4Werther K,Sorensen S,Christensen IJ,et al.Circulating vascularendothelial growth factor six months after primary surgery as aprognostic marker in patients with colorectal cancer[J].Acta On-col,2003,42(8):837-845.
  • 5Ria R,Cirulli T,Giannini T,et al.Serum levels of angiogeniccytokines decrease after radiotherapy in non-Hodgkin lymphomas[J].Clin Exp Med,2008,8(3):141-145.
  • 6Tas F,Duranyildiz D,Oguz H,et al.Serum vascular endothelialgrowth facto(rVEGF)and interleukin-8(IL-8)levels in small celllung cancer[J].Cancer Invest,2006,24(5):492-496.
  • 7Kuroi K,Toi M.Circulating angiogenesis regulators in cancer pa-tients[J].Int J Biol Markers,2001,16(1):5-26.
  • 8国家食品药品监督管理局医疗器械技术审评中心.体外诊断试剂分析性评估(准确度-回收试验)指导原则[S].2010-11-26.
  • 9国家食品药品监督管理局医疗器械技术审评中心.酶联免疫法检测试剂主要原材料、生产工艺及质量控制注册技术审查指导原则(报批稿)[S].2010-11-09.
  • 10国家食品药品监督管理局医疗器械技术审评中心.肿瘤标志物类定量检测试剂注册申报指导原则(征求意见稿)[S].2009-08-27.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部